P2Y12 inhibitor monotherapy better than aspirin for secondary prevention in CAD patients, finds Meta-analysis

Italy: Recent research has demonstrated superior efficacy and similar overall safety of P2Y12 inhibitor monotherapy over aspirin monotherapy for long-term secondary prevention in patients with...

Related Keywords

Italy ,Felice Gragnano ,University Of Campania Luigi Vanvitelli ,Journal Of The American College Cardiology ,Campania Luigi Vanvitelli ,Secondary Prevention ,American College ,Aspirin ,2y12 Inhibitor ,Coronary Artery Disease ,Monotherapy ,Bleeding ,Ticagrelor ,Clopidogrel ,